 Kathryn Chatfield
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Noonan Syndrome | 5 | 2022 | 17 | 2.580 |
Why?
| | Cardiolipins | 3 | 2021 | 72 | 1.310 |
Why?
| | Cardiomyopathies | 5 | 2023 | 303 | 1.170 |
Why?
| | Barth Syndrome | 2 | 2021 | 9 | 0.980 |
Why?
| | Heart Transplantation | 3 | 2019 | 671 | 0.950 |
Why?
| | Electron Transport Complex I | 2 | 2021 | 33 | 0.930 |
Why?
| | Williams Syndrome | 2 | 2021 | 15 | 0.820 |
Why?
| | Mitochondria, Heart | 3 | 2020 | 73 | 0.810 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2021 | 18 | 0.750 |
Why?
| | Myocardium | 5 | 2021 | 926 | 0.700 |
Why?
| | Fatty Acids | 2 | 2021 | 386 | 0.680 |
Why?
| | Cardiomyopathy, Hypertrophic | 4 | 2023 | 120 | 0.670 |
Why?
| | General Practice | 1 | 2019 | 27 | 0.660 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 67 | 0.620 |
Why?
| | Alagille Syndrome | 1 | 2018 | 35 | 0.620 |
Why?
| | DNA, Mitochondrial | 2 | 2020 | 185 | 0.600 |
Why?
| | Mutation | 9 | 2022 | 3364 | 0.580 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2023 | 352 | 0.560 |
Why?
| | Costello Syndrome | 3 | 2023 | 3 | 0.550 |
Why?
| | Heart Defects, Congenital | 4 | 2022 | 659 | 0.540 |
Why?
| | Turner Syndrome | 3 | 2022 | 45 | 0.530 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.500 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.500 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 16 | 0.490 |
Why?
| | ras Proteins | 4 | 2022 | 138 | 0.480 |
Why?
| | Mitochondria | 2 | 2021 | 750 | 0.470 |
Why?
| | Heart Failure | 2 | 2019 | 1963 | 0.460 |
Why?
| | Heart Ventricles | 2 | 2020 | 712 | 0.450 |
Why?
| | De Lange Syndrome | 1 | 2012 | 2 | 0.430 |
Why?
| | Infant | 11 | 2021 | 7979 | 0.410 |
Why?
| | Pyrimidinones | 2 | 2023 | 88 | 0.400 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2021 | 20 | 0.400 |
Why?
| | Pyridones | 2 | 2023 | 125 | 0.390 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1893 | 0.380 |
Why?
| | Child, Preschool | 8 | 2021 | 9133 | 0.370 |
Why?
| | Genetic Association Studies | 1 | 2012 | 343 | 0.360 |
Why?
| | Mydriasis | 2 | 2022 | 9 | 0.360 |
Why?
| | Child | 15 | 2023 | 18488 | 0.350 |
Why?
| | Energy Metabolism | 1 | 2015 | 715 | 0.340 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1310 | 0.320 |
Why?
| | Chromosome Disorders | 2 | 2021 | 34 | 0.300 |
Why?
| | Humans | 34 | 2023 | 115587 | 0.290 |
Why?
| | Phenotype | 4 | 2021 | 2829 | 0.280 |
Why?
| | Female | 20 | 2022 | 59913 | 0.260 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 114 | 0.250 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2022 | 29 | 0.250 |
Why?
| | Acyltransferases | 2 | 2021 | 46 | 0.240 |
Why?
| | Male | 16 | 2021 | 55949 | 0.240 |
Why?
| | Ectodermal Dysplasia | 1 | 2022 | 15 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 2019 | 43 | 0.210 |
Why?
| | Anesthetics | 1 | 2022 | 57 | 0.200 |
Why?
| | Infant, Newborn | 7 | 2018 | 5077 | 0.200 |
Why?
| | Face | 2 | 2020 | 167 | 0.200 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 123 | 0.190 |
Why?
| | Gene Expression | 3 | 2018 | 1435 | 0.190 |
Why?
| | Fetal Diseases | 1 | 2022 | 148 | 0.190 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 924 | 0.190 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 228 | 0.190 |
Why?
| | Genetic Testing | 2 | 2021 | 382 | 0.190 |
Why?
| | Genomic Structural Variation | 1 | 2021 | 7 | 0.190 |
Why?
| | Segmental Duplications, Genomic | 1 | 2021 | 7 | 0.190 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 203 | 0.190 |
Why?
| | Coenzyme A | 1 | 2020 | 6 | 0.180 |
Why?
| | Urinary Bladder | 1 | 2022 | 165 | 0.180 |
Why?
| | Biological Products | 1 | 2023 | 172 | 0.180 |
Why?
| | Craniofacial Abnormalities | 1 | 2021 | 59 | 0.180 |
Why?
| | Actins | 2 | 2022 | 383 | 0.170 |
Why?
| | Liver Diseases | 1 | 2022 | 263 | 0.170 |
Why?
| | Intellectual Disability | 1 | 2021 | 129 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 249 | 0.170 |
Why?
| | Genes, ras | 1 | 2019 | 91 | 0.170 |
Why?
| | Calcium | 2 | 2022 | 1103 | 0.160 |
Why?
| | Electron Transport | 2 | 2020 | 112 | 0.160 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.160 |
Why?
| | Nitrogenous Group Transferases | 1 | 2018 | 2 | 0.160 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2018 | 15 | 0.160 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2018 | 3 | 0.160 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 183 | 0.160 |
Why?
| | Marfan Syndrome | 1 | 2018 | 41 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 344 | 0.160 |
Why?
| | Postoperative Period | 1 | 2019 | 292 | 0.160 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 12 | 0.150 |
Why?
| | Mitochondrial Diseases | 1 | 2018 | 77 | 0.150 |
Why?
| | Seizures | 1 | 2021 | 344 | 0.150 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 225 | 0.150 |
Why?
| | Constriction, Pathologic | 1 | 2018 | 210 | 0.150 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 176 | 0.150 |
Why?
| | Protein Subunits | 1 | 2018 | 204 | 0.150 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 50 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2021 | 3022 | 0.140 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 11 | 0.140 |
Why?
| | NADH Dehydrogenase | 1 | 2017 | 18 | 0.140 |
Why?
| | Acidosis, Lactic | 1 | 2017 | 29 | 0.140 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 167 | 0.140 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 457 | 0.140 |
Why?
| | Adolescent | 6 | 2022 | 17889 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 495 | 0.140 |
Why?
| | Emotions | 1 | 2021 | 477 | 0.140 |
Why?
| | Aorta | 1 | 2018 | 353 | 0.130 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2018 | 117 | 0.130 |
Why?
| | Muscle, Smooth | 3 | 2022 | 150 | 0.130 |
Why?
| | Genetic Diseases, Inborn | 1 | 2016 | 37 | 0.130 |
Why?
| | Echocardiography | 1 | 2018 | 558 | 0.130 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 29 | 0.130 |
Why?
| | Heart | 1 | 2019 | 608 | 0.130 |
Why?
| | Retrospective Studies | 3 | 2021 | 12608 | 0.130 |
Why?
| | Dyskinesias | 1 | 2015 | 11 | 0.120 |
Why?
| | Mental Retardation, X-Linked | 1 | 2015 | 13 | 0.120 |
Why?
| | Cell Respiration | 1 | 2015 | 74 | 0.120 |
Why?
| | Prevalence | 1 | 2021 | 2264 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2016 | 277 | 0.120 |
Why?
| | Comorbidity | 1 | 2019 | 1473 | 0.120 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 81 | 0.120 |
Why?
| | Fibroblasts | 2 | 2018 | 839 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2125 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1700 | 0.110 |
Why?
| | Vascular Stiffness | 1 | 2018 | 411 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 326 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1805 | 0.110 |
Why?
| | Parents | 1 | 2021 | 1205 | 0.110 |
Why?
| | Chondroitin Sulfate Proteoglycans | 1 | 2012 | 9 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1536 | 0.110 |
Why?
| | Transcription Factors | 1 | 2020 | 1528 | 0.100 |
Why?
| | RNA, Messenger | 1 | 2020 | 2574 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 219 | 0.100 |
Why?
| | Genotype | 2 | 2019 | 1786 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 99 | 0.100 |
Why?
| | Registries | 1 | 2019 | 1770 | 0.100 |
Why?
| | Signal Transduction | 3 | 2023 | 4541 | 0.100 |
Why?
| | Syndrome | 2 | 2022 | 339 | 0.090 |
Why?
| | Genomics | 1 | 2014 | 645 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 4665 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 553 | 0.080 |
Why?
| | Pregnancy | 2 | 2018 | 5548 | 0.070 |
Why?
| | Developmental Disabilities | 2 | 2021 | 240 | 0.070 |
Why?
| | Age Factors | 1 | 2014 | 2907 | 0.070 |
Why?
| | Liver | 1 | 2015 | 1690 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 920 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2019 | 9159 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2578 | 0.060 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 36 | 0.060 |
Why?
| | United States | 1 | 2019 | 12295 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2022 | 32 | 0.050 |
Why?
| | Mice | 4 | 2023 | 15052 | 0.050 |
Why?
| | Duodenum | 1 | 2022 | 63 | 0.050 |
Why?
| | Cell Line | 2 | 2021 | 2651 | 0.050 |
Why?
| | Disulfides | 1 | 2022 | 91 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 231 | 0.050 |
Why?
| | Calcium Channels | 1 | 2022 | 146 | 0.050 |
Why?
| | Chromosome Breakpoints | 1 | 2021 | 6 | 0.050 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2021 | 30 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2021 | 53 | 0.050 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.050 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 192 | 0.050 |
Why?
| | Culture Media | 1 | 2021 | 156 | 0.050 |
Why?
| | Myofibrils | 1 | 2021 | 46 | 0.050 |
Why?
| | Chromosome Deletion | 1 | 2021 | 95 | 0.050 |
Why?
| | Sarcomeres | 1 | 2021 | 89 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 238 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 431 | 0.040 |
Why?
| | Adult | 3 | 2018 | 30718 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 549 | 0.040 |
Why?
| | SOS1 Protein | 1 | 2018 | 1 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2020 | 287 | 0.040 |
Why?
| | LEOPARD Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 22 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 390 | 0.040 |
Why?
| | Lentivirus | 1 | 2018 | 46 | 0.040 |
Why?
| | Digoxin | 1 | 2018 | 26 | 0.040 |
Why?
| | Amiodarone | 1 | 2018 | 23 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 131 | 0.040 |
Why?
| | Propranolol | 1 | 2018 | 53 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2023 | 1970 | 0.040 |
Why?
| | Lactoferrin | 1 | 1998 | 28 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2018 | 156 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2018 | 119 | 0.040 |
Why?
| | Animals | 4 | 2023 | 32102 | 0.040 |
Why?
| | Pedigree | 1 | 2018 | 467 | 0.040 |
Why?
| | Inpatients | 1 | 2021 | 380 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2019 | 248 | 0.040 |
Why?
| | Heart Valve Diseases | 1 | 2018 | 116 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 157 | 0.040 |
Why?
| | Mammary Glands, Animal | 1 | 1998 | 116 | 0.040 |
Why?
| | Milk | 1 | 1998 | 124 | 0.040 |
Why?
| | Arginine | 1 | 2018 | 241 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2018 | 390 | 0.030 |
Why?
| | Capital Financing | 1 | 2016 | 5 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 958 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 246 | 0.030 |
Why?
| | Aged | 1 | 2014 | 19251 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 279 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 794 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 56 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 9 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 443 | 0.030 |
Why?
| | Leigh Disease | 1 | 2015 | 17 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 563 | 0.030 |
Why?
| | Aortic Valve | 1 | 2018 | 342 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 770 | 0.030 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2014 | 21 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1361 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2014 | 29 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 482 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 252 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 2000 | 0.030 |
Why?
| | Middle Aged | 1 | 2014 | 26999 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 968 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 2604 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1646 | 0.030 |
Why?
| | Models, Molecular | 1 | 2018 | 1390 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 3914 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 10470 | 0.030 |
Why?
| | Mental Disorders | 1 | 2021 | 902 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 4944 | 0.030 |
Why?
| | Family | 1 | 2016 | 594 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1765 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2016 | 941 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2353 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3069 | 0.020 |
Why?
| | Lactation | 1 | 1998 | 149 | 0.010 |
Why?
| | Iron | 1 | 1998 | 235 | 0.010 |
Why?
|
|
Chatfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|